Understanding New Jersey’s Right‑to‑Know Act and What It Means for Your Operations
New Jersey’s Right‑to‑Know (RTK) Act was created to protect workers and the public by ensuring transparency about hazardous substances used in workplaces.
For the pharmaceutical industry, this means every manufacturer, packaging facility, and distributor operating within the state must clearly identify and label hazardous chemicals in accordance with state‑specific regulations.
The NJ RTK Act requires businesses to maintain accessible chemical information through proper labeling, hazardous substance inventories, and employee training.
In the context of pharma labeling requirements, compliance ensures employees can handle materials safely while maintaining environmental and public health standards.
Failure to comply can result in hefty fines, shutdown orders, or reputational damage, making it essential for pharmaceutical companies to understand exactly what is required on their labels.
What Must Be Included on Right‑to‑Know Labels Under NJ Law
Under New Jersey’s Right‑to‑Know regulations (N.J.A.C. 8:59), labels must be clear, durable, and prominently displayed on all containers holding hazardous substances. Each label must include:
- Chemical name(s) of all hazardous ingredients listed on the state’s RTK Hazardous Substance List.
- CAS (Chemical Abstracts Service) numbers for accurate identification.
- Appropriate hazard warnings, such as flammability, toxicity, or corrosivity.
- Manufacturer or employer information for traceability and accountability.
In pharmaceutical settings, Right‑to‑Know labeling often applies to laboratory chemicals, solvents, and cleaning agents used in production and packaging—not just finished drug products.
Ensuring that these materials are properly labeled helps maintain FDA‑compliant operations and workplace safety simultaneously.
How New Jersey Right‑to‑Know Labeling Requirements Differ from Federal OSHA and GHS Standards
While the OSHA Hazard Communication Standard (HCS) and the Globally Harmonized System (GHS) both require hazard labeling, New Jersey’s RTK program adds state‑specific obligations.
Key differences include the following:
- State Hazardous Substance List: New Jersey maintains its own list of regulated substances that may not appear on federal lists.
- Label language: NJ RTK labels must use chemical names exactly as listed by the state, not trade names or abbreviations.
- Additional worker access: Employers must keep RTK Hazardous Substance Fact Sheets available for all listed chemicals.
This means dual compliance for pharmaceutical companies, as your federal OSHA/GHS labels may not fully meet New Jersey regulations. To prevent compliance gaps, it is essential to make sure both systems are in sync.
For pharmaceutical companies, this means dual compliance—your federal OSHA/GHS labels might not fully satisfy NJ requirements. Ensuring both systems align is critical to avoiding compliance gaps.
Common Right‑to‑Know Compliance Mistakes—and How to Avoid Costly Penalties
Even well‑established pharmaceutical companies can fall short on RTK labeling due to oversight or misunderstanding.
Common pitfalls include:
- Using trade names instead of chemical names—which violates New Jersey’s labeling rules.
- Failing to update labels when formulations or chemical suppliers change.
- Relying solely on OSHA or GHS labeling without adding NJ‑specific details.
- Neglecting to train employees on how to read and interpret RTK labels.
To stay compliant:
- Conduct regular audits of all hazardous substance containers.
- Verify that labels match the NJ RTK Hazardous Substance List.
- Maintain a centralized compliance documentation system accessible to all employees.
- Partner with a compliance‑focused labeling provider who understands both state and federal standards.
Need a Labeling Partner Who Understands New Jersey Compliance?
Navigating New Jersey’s Right‑to‑Know labeling requirements can be complex—especially for pharmaceutical operations balancing FDA, OSHA, and state health regulations.
That’s where we came in. Based in New Jersey, Miniature Folding, Inc. specializes in pharma labeling and packaging solutions that meet both federal and state compliance standards. Our team ensures every label is accurate, durable, and fully aligned with New Jersey’s RTK and GHS guidelines—protecting your workers, your brand, and your business from costly penalties.
Whether you’re updating your current labeling system or launching a new production line, our expertise helps you achieve total compliance with confidence.
Learn how to streamline your pharma labeling requirements and keep your operations compliant across New Jersey’s evolving regulatory landscape. Click here today and request your free estimate!